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Introduction
The adverse effects of smoking on coronary artery disease have been well described over the past decades. Previous studies showed that smoking was strongly related to the progression of coronary artery disease as well as the incidence of (cardiac) death 1-3 4,5 and myocardial infarction. Others showed improved survival and a lower incidence 6-9 10-14 of myocardial (re)infarction after smoking cessation. In consequence of these results 15, 16 and the present restricted resources, there has recently been controversy about the question whether smokers should have the same opportunities for coronary bypass surgery as non smokers. However, effects of smoking and smoking cessation after coronary 17, 18 bypass surgery on the need for re-operation and coronary angioplasty and the return of angina pectoris have not been well described. To determine the influence of smoking and smoking cessation not only on the incidence of death and myocardial infarction, but also on re-intervention and angina pectoris, we analyzed the results in a group of 446 consecutive patients who underwent venous coronary bypass surgery in 1976/1977 and were prospectively followed for 15 years.
Methods
Patients: A consecutive series of 446 patients underwent isolated aortocoronary saphesmoking after coronary bypass surgery 59
nous-vein bypass surgery with or without resection of a left ventricular aneurysm at the St.Antonius Hospital, formerly in Utrecht and now in Nieuwegein, the Netherlands, between April 1, 1976 and April 1, 1977 . Eighteen patients in whom the operation was combined with a valve replacement were excluded from analysis. Thirteen patients died within 30 days after the procedure. The study-group of the 415 remaining patients consisted of 372 men and 43 women with a mean age of 52.5 years (range 20-73). Other characteristics of the smokers and non-smokers at baseline, are presented in table 1 . Follow-up and data collection: Several follow-up methodologies were used simultaneously in order to receive the most complete information as possible. All patients were followed using the anniversary method at our outpatient clinic of the referring cardiologists. All patients except one, who went abroad and was lost to follow-up 7 years after surgery, were traced at the common closing date of April 1, 1992.
Definitions: Smoking behavior.
A smoker was a patient who smoked at time of surgery and/or smoked at one year after surgery. A permanent smoker was defined as a patient who smoked at surgery, at one year after surgery and at five years after surgery. A nonsmoker was a patient who never smoked or who smoked in the past, but did not smoke at time of surgery or afterwards. We defined a quitter since surgery as a patient who stopped smoking since surgery and did not smoke at one year and five years respectively. A recidivist smoker was a patient who stopped smoking but resumed smoking within five years after surgery. The severity of Angina Pectoris was scored according to the guidelines of the Canadian Cardiovascular Society (CCS) and left ventricular function was scored according 19 to the Coronary Artery Surgery Study (CASS) registry.
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A myocardial infarction was diagnosed in case of a) large Q waves associated with changes in the S-T segments and T-waves in specific and appropriate leads that indicate the location of the infarct or b) specific enzyme alterations in combination with localized serial T waves changes. Endpoints: As clinical endpoints were considered: death, myocardial infarction, recoronary bypass surgery, coronary angioplasty and recurrence of angina pectoris.
The endpoints were scored in a hierarchical way. Angina pectoris was only scored as an endpoint when until that moment, no other endpoint was reached. Myocardial infarction was only scored when a patient did not already have to undergo a reintervention procedure, and re-coronary bypass surgery and coronary angioplasty were only scored when they were the first postoperative re-intervention procedure. In all other situations, these events were considered as censored. This was done to avoid the confounding effect of one event causing another, for example a coronary angioplasty procedure causing a myocardial infarction.
Comparisons
Event rates between the following groups were multivariately analyzed at three different time intervals: 1. From surgery to 15 years after surgery: smokers compared to non-smokers 2. From 1 to 15 years after surgery: smokers compared to quitters since surgery 3. From 5 to 15 years after surgery: -permanent smokers and recidivist-smokers compared to quitters since surgery -permanent smokers, recidivist-smokers and quitters since surgery compared to nonsmokers When groups were compared from 1 to 15 years and from 5 to 15 years, events which had occurred before one and five years respectively, were censored. Statistical Analysis: To identify prognostic covariates that might have "explained" a difference in survival time between the smokers-group and the non-smokers-group we estimated survival curves by the method described by Kaplan and Meier from the 21 following variables: age, sex, obesity (body-mass index: weight/height²), diabetes mellitus, elevated levels of serum cholesterol and triglycerides, hypertension, history of heart failure, preoperative angina pectoris, family history of coronary artery disease, number of vessels diseased, completeness of revascularization, number of distal anastomoses, left ventricular function, history of myocardial infarction, operation indication, the presence of collateral arteries, left main coronary artery disease and proximal left anterior descending artery disease. Differences in survival times between groups were calculated using the log-rank and the Wilcoxon tests. All variables with a significance level of p<0.10 in at least one of these univariate tests, were introduced in a multivariate model proposed by Cox. Age and gender were always included. Smoking behavior was 22 finally added to the model. We checked the assumption of proportional hazards for each predictor variable by estimating the plots of the logarithm of the cumulative hazard. By using this analysis we could predict the independent influence of smoking on different cardiac events in this population. The risk of a smoker on having a cardiac event in relation to a non-smoker is reflected by the hazard ratio (HR).
Results
Follow-up was complete in 99.8% and averaged 15.4 years for the survivors. Thirteen patients (3%) died within 30 days after surgery. These patients were not included for analysis. Long-term results this study-group have been described elsewhere. The 23 distribution of smokers, non-smokers, quitters since surgery, permanent smokers and recidivist smokers at time of surgery and at one and five years after surgery, are presented in table 2.
Death
Of the 169 smokers at time of surgery, 66 (39%) died within 15 years, while death of cardiac causes occurred in 23% of the smokers. Death occurred in 91 of the 244 (37%) non-smokers at surgery, of whom 56 (23%) were cardiac deaths. From surgery to 15 years afterwards, multivariate Cox survival analysis revealed no significantly increased mortality for smokers compared to non-smokers (table 3) , and analysis from one to five years after surgery did not reveal significant differences in mortality between smokers, quitters since surgery, and non-smokers.(table 4) Although analysis from five to 15 years after surgery yielded an elevated mortality risk of 1.7 times for permanent smokers compared to quitters since surgery, mortality risk was not significantly increased. (table 6 ) Also, mortality rates between recidivist smokers, quitters since surgery, and permanent smokers, compared to non-smokers, from five to 15 years after surgery, did not differ significantly. (table 6 ) Death from cardiac causes was also comparable between the groups at all three different time intervals. 
Myocardial Infarction
From surgery to 15 years afterwards, no significant differences in myocardial infarction rate were found between smokers and non-smokers.(table 3) However, from one to 15 years after surgery, myocardial infarction rate for the smokers was 29%, compared to 17% of the patients who stopped smoking since surgery. Multivariate analysis revealed that at one year after surgery, smokers had an elevated risk of 2.3 times on myocardial infarction compared to the quitters since surgery (p=0.04) in the subsequent follow-up period.(table 4) From five to 15 years after surgery, permanent smokers had a 2.5 times increased risk for myocardial infarction, compared to quitters since surgery (p=0.04, table 6), and a 2.4 times increased risk, compared to nonsmokers.(p=0.008, table 6) The risk for recidivist smokers on myocardial infarction from 5 to 15 years after surgery was not significantly increased (1.9 and 1.8 times) compared to quitters since surgery and to non-smokers respectively. Myocardial infarction rate from 5 to 15 years after surgery for quitters since surgery and nonsmokers was comparable. (table 6) 
Re-coronary bypass surgery
From baseline coronary bypass surgery to 15 years afterwards, 28 of the 164 patients who smoked at time of surgery had to undergo re-operation compared to 42 of the 244 baseline-non-smokers.(not significant, table 3) Per-operative mortality of this reoperation procedure was 7.1% in both groups. Most patients were re-operated because of recurrence of angina pectoris. Emergency bypass surgery because of an unsuccessful smoking after coronary bypass surgery 63 coronary angioplasty was censored in our analysis. In the baseline-smokers group, three patients (7%) had a recent myocardial infarction before surgery, compared with two baseline-non-smokers (7%). Patients who smoked at one year after surgery had a 2.5 times elevated risk to undergo a re-operation, compared to patients who quitted smoking since surgery (p=0.03).(table 4) Moreover, the risk for the need of reoperation for patients who were still smoking at five years after surgery (permanent smokers) was 3.3 times (p=0.03), compared to quitters since surgery. Also, patients who started to smoke again within five years (recidivist smokers) had an elevated risk of 3.4 times (p=0.04) on re-operation, compared to quitters since surgery. (table 6) Compared to non-smokers, risks for permanent smokers and recidivist smokers were significantly increased, while the quitters since surgery had comparable outcome. (table  6) 
Coronary Angioplasty
Fifty-seven patients underwent a coronary angioplasty as a first re-intervention procedure after their coronary bypass surgery. Total per-procedural mortality was 2%, and did not differ between smokers and non-smokers. Most patients underwent coronary angioplasty because of recurrence of angina pectoris. A recent myocardial infarction (<1 month before coronary angioplasty) was found in 12% of the patients. Comparisons between smokers, nonsmokers, quitters since surgery, permanent smokers and recidivist smokers, did not reveal significant differences in coronary angioplasty rate. However, there was a trend for an increased risk for the need of coronary angioplasty for recidivist smokers and permanent smokers, compared to non-smokers, while event rates between quitters since surgery and non-smokers were comparable.(table 6) 
Angina Pectoris
After 15 years, only 27% of the patients from the entire study population was still free from angina pectoris. From surgery to 15 years afterwards and from one to 15 years after surgery, event rates for the return of angina pectoris between smokers, nonsmokers, and quitters since surgery, were not significantly different. However, patients who were still smoking at five years after surgery or started to smoke within five years after surgery had, compared to patients who ceased smoking since surgery, a more than twofold increased risk for the return of angina pectoris. (table 6 ) Again, the return of angina pectoris was comparable between quitters since surgery and non-smokers. (table  6) 
Discussion
Recently, there has been much controversy about the question whether smokers should receive the same opportunity for coronary bypass surgery as non-smokers, and 17, 18 smoking after coronary bypass surgery 65 proposals have been made to hold smokers accountable for heart disease costs. 24 Discussion about this subject was based mainly on the consistent finding that continued smoking after coronary bypass surgery increases mortality and myocardial infarction rate. However, to the best of our knowledge, no data are available on the risks for death and myocardial infarction after coronary bypass of patients who continued to smoke or who started to smoke again after surgery compared with patients who stopped smoking since surgery. Moreover, questions about the risks for re-operation and coronary angioplasty after coronary bypass surgery for smokers also have remained unanswered.
The results of this study showed that patients who continued to smoke or patients who started to smoke again after coronary bypass surgery, had increased risks not only for myocardial infarction but also for re-coronary bypass surgery and recurrence of angina pectoris compared with patients who stopped smoking since surgery and patients who did not smoke. Moreover, clinical outcome after surgery for patients who stopped smoking since surgery was similar to non-smokers.
In contrast with other studies, we did not find a strong relationship between smoking behavior and survival. A possible explanation could be that the deleterious effects of smoking may not only be mediated by the chronic process of atherosclerotic progression in the grafts and the native system: smoking is also positively correlated with immediate peri-operative morbidity and mortality, mainly due to pulmonary infections. Because 25 we aimed to describe the longterm effects of smoking and smoking cessation, we did not include patients who died within 30 days after surgery, which could have biased the results.
The association between smoking behaviour and myocardial infarction is already recognized. Hartz et al. found a significant association between smoking and myocar- Our findings that smoking had an increased hazard for the return of angina pectoris supports the results from the CASS study, in which it was found that smokers, in 14 comparison with non-smokers, were less likely to remain free from angina pectoris after ten years in both the patient-group randomized to medical treatment and the coronary bypass surgery group. There are few other studies that examine the influence of smoking after coronary bypass surgery on angina pectoris. Moreover, hardly any data are available about the effects of smoking behavior on the need for re-intervention either operative or by angioplasty.
We report on the effects of smoking behavior on clinical events after venous coronary bypass surgery. At present, it has been shown that arterial grafts might have an improved outcome over venous grafts.
However, for a variety of reasons, venous 26, 27 grafts are continued to be used in the majority of coronary bypass surgery patients, mostly in combination with arterial grafts.
Since it is conceivable that the venous [28] [29] [30] conduits will be the first to cause clinical events, factors that influence the clinical outcome of patients with venous grafts, will remain to be important for the present situation. This study has some shortcomings. Firstly, we did not assess the total life consumption of cigarettes and although we recorded number of cigarettes smoked, groups became too small to detect any significant differences. Secondly, there may have been other factors, intercorrelating with smoking behavior, that we dit not record. For example, social status was not recorded, although differences in social status in the Netherlands are very small. Finally, smoking status was assessed by asking patients about their smoking behavior. We were not able to check the expressed smoking behaviour by biochemical validation, which remains a possible source of bias.
Despite these imperfections, on the basis of our prospective, multivariate analysis, there is a strong indication that patients who continue to smoke or start smoking again after coronary bypass surgery, not only have an elevated risk for myocardial infarction, but also for the return of angina pectoris and the need for re-coronary bypass surgery. Therefore we conclude that smoking cessation after coronary bypass surgery may have important beneficial effects on long-term cardiac morbidity.
